A comparison of the effects of valproate and its major active metabolite E-2-en-valproate on single unit activity of substantia nigra pars reticulata neurons in rats1

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1305-1314

  Rohlfs, Anke ^a,b   Rundfeldt, Chris ^a,c   Koch, Rainer ^a   Löscher, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b Battelle Geneva Research Center   (Switzerland)

^c Arzneimittel Werk Dresden ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; VALPROIC ACID; VALPROIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SINGLE UNIT ACTIVITY; SUBSTANTIA NIGRA;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MEMBRANE POTENTIALS; NEURONS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; VALPROIC ACID;

EID: 0030426816     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. ALTRUP, U., GERLACH, G., REITH, H., SAID, M. N. AND SPECKMANN, E.-J.: Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia: I. Antiepileptic actions. Epilepsia 33: 743-752, 1992.
2. BONHAUS, D. W., RUSSELL, R. D. AND MCNAMARA, J. O.: Activation of substantia nigra pars reticulate neurons: Role in the initiation and behavioral expression of kindled seizures. Brain Res. 545: 41-48, 1991.
3. CONDE, H.: Organization and physiology of the substantia-nigra. Exp. Brain Res. 88: 233-248, 1992.
4. COTARIU, D., ZAIDMAN, J. L. AND EVANS, S.: Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system. Progr. Neurobiol. 34: 343-354, 1990.
5. DENIAU, J. M. AND CHEVALIER, G.: The lamellar organization of the rat substantia nigra pars reticulata: Distribution of projection neurons. Neuroscience 46: 361-367, 1992.
6. FALLON, J. H. AND LOUGHLIN, S. E.: Substantia nigra. In: The Rat Nervous System. Volume 1. Forebrain and Midbrain, ed. by G. Paxinos, pp. 353-374, Academic Press, Sydney, 1985.
7. FARRANT, M. AND WEBSTER, R. A.: Neuronal activity, amino acid concentration and amino acid release in the substantia nigra of the rat after sodium valproate. Brain Res. 504: 49-56, 1989.
8. FISHER, E., WITTFOHT, W. AND NAU, H.: Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry. Biomed. Chromatogr. 6: 24-29, 1992.
9. GALE, K.: Mechanisms of seizure control mediated by γ-aminobutyric acid: Role of the substantia nigra. Fed. Proc. 44: 2414-2424, 1985.
10. GALE, K.: Progression and generalization of seizure discharge: Anatomical and neurochemical substrates. Epilepsia 29 (Suppl. 2): S15-S34, 1988.
11. GALE, K.: GABA and epilepsy: Basic concepts from preclinical research. Epilepsia 33 (Suppl. 5): S3-S12, 1992.
12. GARANT, D. S. AND GALE, K.: Substantia nigra-mediated anticonvulsant actions: Role of nigral output pathways. Exp. Neurol. 97: 143-159, 1987.
13. GRACE, A. A. AND BUNNEY, B. S.: Paradoxical GABA excitation of nigral dopaminergic neurons: Indirect mediation through reticulata inhibitory neurons. Eur. J. Pharmacol. 59: 211-218, 1979.
14. GRACE, A. A. AND BUNNEY, B. S.: Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res. 333: 271-284, 1985.
15. GUYENET, P. G. AND AGHAJANIAN, G. K.: Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra. Brain Res. 150: 69-84, 1978.
16. IADAROLA, M. J. AND GALE, K.: Dissociation between drug-induced increases in nerve terminal and non-nerve terminal pools of GABA in vivo. Eur. J. Pharmacol. 59: 125-129, 1979.
17. KERWIN, R. W., OLPE, H.-R. AND SCHMUTZ, M.: The effect of sodium-n-dipropylacetate on γ-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity. Br. J. Pharmacol. 71: 545-551, 1980.
18. KURUVILLA, A. AND URETSKY, N. J.: Effect of sodium valproate on motor function regulated by the activation of GABA receptors. Psychopharmacology 72: 167-172, 1981.
19. LÖSCHER, W.: Valproate enhances GABA turnover in the substantia nigra. Brain Res. 501: 198-203, 1989.
20. 2(E)-valproate in animals. Pharm. Weekblad 14: 139-143, 1992.
21. LÖSCHER, W.: In vivo administration of valproate reduces the nerve terminal (synaptoeomal) activity of GABA aminotransferase in discrete brain areas of rats. Neurosci. Lett. 160: 177-180, 1993a.
22. LÖSCHER, W.: Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem. Res. 18: 485-502, 1993b.
23. LÖSCHER, W., BÖHME, G., SCHÄFER, H. AND KOCHEN, W.: Effect of metabolites of valproic acid on the metabolism of GABA in brain and brain nerve endings. Neuropharmacology 20: 1187-1192, 1981.
24. LÖSCHER, W. AND EBERT, U.: Basic mechanisms of seizure propagation: Targets for rational drug design and rational polypharmacy. Epilepsy Res., in press.
25. LÖSCHER, W., HÖNACK, D., NOLTING, B. AND FAßBENDER, C. P.: Trans-2-envalproate: Reevaluation of its anticonvulsant efficacy in standardized seizure models in mice, rats and dogs. Epilepsy Res. 9: 195-210, 1991.
26. LÖSCHER, W., ROHLFS, A. AND RUNDFELDT, C.: Reduction in firing rate of substantia nigra pars reticulate neurons by valproate: Influence of different types of anesthesia in rate. Brain Res. 702: 133-144, 1995.
27. LÖSCHER, W. AND VETTER, M.: Drug-induced changes in GABA content of nerve endings in 11 rat brain regions: Correlation to pharmacological effects. Neurosci. Lett. 47: 325-331, 1984.
28. MCLEAN, M. J. AND MACDONALD, R. L.: Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J. Pharmacol. Exp. Ther. 237: 1001-1011, 1986.
29. NAU, H. AND LÖSCHER, W.: Valproic acid and metabolites: Pharmacological and texicological studies. Epilepsia 25: 14-22, 1984.
30. OERTEL, W. H. AND MUGNAINI, E.: Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neurosci. Lett. 47: 233-238, 1984.
31. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney, 1986.
32. ROHLFS, A., RUNDFELDT, C. AND LÖSCHER, W.: Single unit recordings in the substantia nigra pars reticulate of rats: Effects of the anticonvulsant drugs valproate and trans-2-en-valproate on the spontaneous activity of GABAergic neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 347 (Suppl.): R139, 1993a.
33. ROHLFS, A., RUNDFELDT, C. AND LÖSCHER, W.: Single unit recordings in the substantia nigra of rats: Influence of the anesthesia on spontaneous activity of GABAergic neurons and on the effect of the anticonvulsant drug valproate. Soc. Neurosci. Abstr. 19: 163, 1993b.
34. ROHLFS, A.: Extrazelluläre Einzelzellableitungen in der Substantia nigra pars reticulata bei Ratten: Vergleich der Wirkung verschiedener Antikonvulsiva auf die Spontanaktivität GABAerger Neuronen unter Berücksichtigung verschiedener Anaeathesieformen, Doctoral Thesis, School of Veterinary Medicine, Hannover, 1994.
35. RUNDFELDT, C., ROHUS, A. AND LÖSCHER, W.: Single unit recordings in the substantia nigra pars reticulata of rats: Influence of anesthesia on the effects of the anticonvulsant drugs valproate and trans-2-en-valproate on the spontaneous activity of GABAergic neurons. In Gene-Brain-Behaviour. Proceedings of the 21th Göttingen Neurobiology Conference, ed. by N. Elsner and M. Heisenberg, p. 690, Thieme, Stuttgart, 1993.
36. SAYIN, U., TIMMERMAN, W. AND WESTERINK, B. H. C.: The significance of extracellular GABA in the substantia nigra of the rat during seizures and anti-convulsant treatments. Brain Res. 669: 67-72, 1995.
37. 2-valproate and valproate in rats. Epilepsia 32: 232-241, 1991.
38. A receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. J. Neurosci. 15: 3092-3103, 1995.
39. TIMMERMANN, W., ZWAVELING, J. AND WESTERINK, B. H. C.: Characterization of extracellular GABA in the substantia nigra reticulata by means of brain microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 348: 661-665, 1992.
40. TURSKI, L., ANDREWS, J. S., LÖSCHMANN, P. A., BRESSLER, K., BORTOLOTTO, Z. A., CALDERAZZO-FILHO, L. S. AND CAVALHEIRO, E. A.: Substantia nigra regulates action of antiepileptic drugs. Brain Res. 520: 232-239, 1990.
41. WASZCZAK, B. L., ENG, N. AND WALTERS, J. R.: Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons. Brain Res. 188:185-197, 1980.
42. WASZCZAK, B. L., LEE, E. K. AND WALTERS, J. R.: Effects of anticonvulsant drugs on substantia nigra pars reticulata neurons. J. Pharmacol. Exp. Ther. 239: 606-611, 1986.
43. ZHANG, J., CHIODO, L. A. AND FREEMAN, A. S.: Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl)guanidine on non-dopaminergic midbrain neurons. Eur. J. Pharmacol. 230: 371-374, 1993.